Home/Filings/4/0001144204-16-083700
4//SEC Filing

TITAN PHARMACEUTICALS INC 4

Accession 0001144204-16-083700

$TTNPCIK 0000910267operating

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 8:32 PM ET

Size

5.8 KB

Accession

0001144204-16-083700

Insider Transaction Report

Form 4
Period: 2016-02-22
BHONSLE SUNIL
DirectorPresident
Transactions
  • Purchase

    Common Stock

    2016-02-22$3.56/sh+11,763$41,817125,578 total
Holdings
  • Common Stock

    (indirect: By Trust)
    54,684
Footnotes (2)
  • [F1]Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $3.50 to $3.61. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F2]The reporting person serves as trustee of the family trust.

Issuer

TITAN PHARMACEUTICALS INC

CIK 0000910267

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000910267

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 8:32 PM ET
Size
5.8 KB